Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage?

Por Bessone, Fernando
Publicado em 2010

Management of hepatitis B reactivation in immunosuppressed patients: An update on current recommendations

Por Bessone, Fernando, Dirchwolf, Melisa
Publicado no World J Hepatol (2016)

Challenge of liver disease in systemic lupus erythematosus: Clues for diagnosis and hints for pathogenesis

Por Bessone, Fernando, Poles, Natalia, Roma, Marcelo G
Publicado em 2014

The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative

Por Bessone, Fernando, Hernandez, Nelia, Lucena, M. Isabel, Andrade, Raúl J.
Publicado no Int J Mol Sci (2016)

High Prevalence of Hepatitis C Virus Genotype 1b Infection in a Small Town of Argentina. Phylogenetic and Bayesian Coalescent Analysis

Por Golemba, Marcelo D., Di Lello, Federico A., Bessone, Fernando, Fay, Fabian, Benetti, Silvina, Jones, Leandro R., Campos, Rodolfo H.
Publicado em 2010

Hepatitis C virus infection in Argentina: Burden of chronic disease

Por Ridruejo, Ezequiel, Bessone, Fernando, Daruich, Jorge R, Estes, Chris, Gadano, Adrián C, Razavi, Homie, Villamil, Federico G, Silva, Marcelo O
Publicado no World J Hepatol (2016)

Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: results from the 2-year roadmap strategy

Por Piratvisuth, Teerha, Komolmit, Piyawat, Chan, Henry LY, Tanwandee, Tawesak, Sukeepaisarnjaroen, Wattana, Pessoa, Mário G, Fassio, Eduardo, Ono, Suzane K, Bessone, Fernando, Daruich, Jorge, Zeuzem, Stefan, Manns, Michael, Uddin, Alkaz, Dong, Yuhong, Trylesinski, Aldo
Publicado no Drugs Context (2016)

52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B

Por Piratvisuth, Teerha, Komolmit, Piyawat, Tanwandee, Tawesak, Sukeepaisarnjaroen, Wattana, Chan, Henry L. Y., Pessôa, Mário G., Fassio, Eduardo, Ono, Suzane K., Bessone, Fernando, Daruich, Jorge, Zeuzem, Stefan, Cheinquer, Hugo, Pathan, Rashidkhan, Dong, Yuhong, Trylesinski, Aldo
Publicado em 2013

Pre-treatment prediction of response to peginterferon plus ribavirin in chronic hepatitis C genotype 3

Por Marciano, Sebastián, Borzi, Silvia M, Dirchwolf, Melisa, Ridruejo, Ezequiel, Mendizabal, Manuel, Bessone, Fernando, Sirotinsky, María E, Giunta, Diego H, Trinks, Julieta, Olivera, Pablo A, Galdame, Omar A, Silva, Marcelo O, Fainboim, Hugo A, Gadano, Adrián C
Publicado no World J Hepatol (2015)

Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-wide Association Study

Por Nicoletti, Paola, Aithal, Guruprasad P., Bjornsson, Einar S., Andrade, Raul J., Sawle, Ashley, Arrese, Marco, Barnhart, Huiman X., Bondon-Guitton, Emmanuelle, Hayashi, Paul H., Bessone, Fernando, Carvajal, Alfonso, Cascorbi, Ingolf, Cirulli, Elizabeth T., Chalasani, Naga, Conforti, Anita, Coulthard, Sally A., Daly, Mark J., Day, Christopher P., Dillon, John F., Fontana, Robert J., Grove, Jane I., Hallberg, Pär, Hernández, Nelia, Ibáñez, Luisa, Kullak-Ublick, Gerd A., Laitinen, Tarja, Larrey, Dominique, Lucena, M. Isabel, Maitland-van der Zee, Anke H., Martin, Jennifer H., Molokhia, Mariam, Pirmohamed, Munir, Powell, Elizabeth E., Qin, Shengying, Serrano, Jose, Stephens, Camilla, Stolz, Andrew, Wadelius, Mia, Watkins, Paul B., Floratos, Aris, Shen, Yufeng, Nelson, Matthew R., Urban, Thomas J., Daly, Ann K.
Publicado no Gastroenterology (2016)